Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1946 4
1947 10
1948 12
1949 9
1950 35
1951 24
1952 15
1953 29
1954 31
1955 32
1956 39
1957 44
1958 47
1959 35
1960 21
1961 20
1962 42
1963 134
1964 184
1965 179
1966 148
1967 187
1968 215
1969 248
1970 262
1971 246
1972 271
1973 268
1974 272
1975 279
1976 219
1977 256
1978 202
1979 219
1980 193
1981 184
1982 232
1983 241
1984 234
1985 255
1986 262
1987 199
1988 185
1989 163
1990 164
1991 160
1992 129
1993 140
1994 131
1995 150
1996 119
1997 157
1998 156
1999 176
2000 208
2001 262
2002 280
2003 395
2004 476
2005 692
2006 748
2007 892
2008 1047
2009 1201
2010 1446
2011 1626
2012 1777
2013 1942
2014 2208
2015 2438
2016 2632
2017 2696
2018 2747
2019 1369
2020 33
Text availability
Article attribute
Article type
Publication date

Search Results

31,753 results
Results by year
Filters applied: . Clear all
Page 1
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
Dietrich P and Hellerbrand C. Best Pract Res Clin Gastroenterol 2014 - Review. PMID 25194181
Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in developed countries and its incidence is still rising. ...NASH is characterized by liver inflammation and injury thereby determining the risk to develop liver fibrosis and cancer. NAFLD is considered the hepatic manifestation of the metabolic syndrome. ...
Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of chronic liver disease worldwide. …
The global NAFLD epidemic
Loomba R and Sanyal AJ. Nat Rev Gastroenterol Hepatol 2013 - Review. PMID 24042449
NAFLD is a clinical syndrome characterized by predominant macrovesicular steatosis of the liver. The clinical and histological phenotypes of NAFLD extend from a nonalcoholic fatty liver to NASH. Although the prevalence of NAFLD is increasing globally, and it is set to become the predominant cause of chronic liver disease in many parts of the world, the epidemiology and demographic characteristics of NAFLD vary worldwide. ...
NAFLD is a clinical syndrome characterized by predominant macrovesicular steatosis of the liver. The clinical and histological phenot …
Postpartum acute fatty liver of pregnancy: a case report.
Al-Husban N, et al. J Med Case Rep 2018. PMID 29855383 Free PMC article.
BACKGROUND: Acute fatty liver of pregnancy can be a very dramatic clinical event with significant risk of mortality to healthy women. ...CONCLUSIONS: The clinical presentation of acute fatty liver of pregnancy is very variable and nonspecific. Skin rash can be a new presenting symptom of acute fatty liver of pregnancy. ...
BACKGROUND: Acute fatty liver of pregnancy can be a very dramatic clinical event with significant risk of mortality to healthy …
Hepatic Steatosis: Etiology, Patterns, and Quantification
Idilman IS, et al. Semin Ultrasound CT MR 2016 - Review. PMID 27986169
Hepatic steatosis can occur because of nonalcoholic fatty liver disease (NAFLD), alcoholism, chemotherapy, and metabolic, toxic, and infectious causes. ...Focal steatosis and fat sparing can occur because of the presence of veins of Sappey, pancreaticoduodenal vein, and aberrant right and left gastric veins, which drain into the liver as third inflow. ...
Hepatic steatosis can occur because of nonalcoholic fatty liver disease (NAFLD), alcoholism, chemotherapy, and metabolic, toxi …
Innate Immunity and Inflammation in NAFLD/NASH
Arrese M, et al. Dig Dis Sci 2016 - Review. PMID 26841783 Free PMC article.
Inflammation and hepatocyte injury and death are the hallmarks of nonalcoholic steatohepatitis (NASH), the progressive form of nonalcoholic fatty liver disease (NAFLD), which is a currently burgeoning public health problem. ...Thus, identification of the underlying mechanisms by which immune cells in the liver recognize cell damage signals or the presence of pathogens or pathogen-derived factors that activate them is relevant from a therapeutic perspective. ...
Inflammation and hepatocyte injury and death are the hallmarks of nonalcoholic steatohepatitis (NASH), the progressive form of nonalcoholic …
Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
Ma YY, et al. World J Gastroenterol 2013 - Review. PMID 24187469 Free PMC article.
AIM: To investigate the relationship between the gut-liver axis and nonalcoholic fatty liver disease (NAFLD), we performed a meta-analysis to evaluate the effects of probiotic therapy in NAFLD. ...CONCLUSION: Probiotic therapies can reduce liver aminotransferases, total-cholesterol, TNF-α and improve insulin resistance in NAFLD patients. ...
AIM: To investigate the relationship between the gut-liver axis and nonalcoholic fatty liver disease (NAFLD), we perfor …
Autoimmune hepatitis, fatty liver, and Fukushima.
Takahashi A and Ohira H. Fukushima J Med Sci 2019 - Review. PMID 31270280 Free PMC article.
Autoimmune hepatitis (AIH) remains to be an issue in liver disease after the DAAs era. Moreover, fatty liver had been increasing in incidence and has attracted attention because of its risk for hepatocellular carcinoma. ...In this manuscript, we outlined the recent topics about AIH, fatty liver, and Fukushima....
Autoimmune hepatitis (AIH) remains to be an issue in liver disease after the DAAs era. Moreover, fatty liver had been i …
Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.
Musso G, et al. Ann Med 2011. PMID 21039302
The natural history of NAFLD and the optimal strategy to identify subjects with progressive liver disease are unclear. Objectives. ...NAFLD has an increased overall mortality (OR: 1.57, 95% CI: 1.18-2.10), deriving from liver-related and cardiovascular disease, and a 2-fold risk of diabetes. ...
The natural history of NAFLD and the optimal strategy to identify subjects with progressive liver disease are unclear. Objectives. .. …
Obesity and the liver: nonalcoholic fatty liver disease.
Koppe SW. Transl Res 2014 - Review. PMID 25028077
The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) parallels the rise of obesity and its complications. NAFLD is a common cause of cirrhosis and a leading indication for liver transplant. ...Some patients will develop hepatocyte cellular injury and fibrosis of the liver, which can progress to cirrhosis and require liver transplant. ...
The increasing prevalence of nonalcoholic fatty liver disease (NAFLD) parallels the rise of obesity and its complications. NAF …
31,753 results
Jump to page
Feedback